Factors of treatment response in major depressive disorder
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Duloxetine; Escitalopram; Venlafaxine
- Indications Major depressive disorder
- Focus Therapeutic Use
- 21 Sep 2008 Status changed from recruiting to suspended as reported by Clinicaltrials.gov.
- 11 Aug 2008 Planned number of patients changed from 120 to 140 as reported by ClinicalTrials.gov.
- 21 Apr 2008 The expected completion date for this trial is now 1 Jun 2009.